Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Who's most at risk if the U.S. cracks down on prices? Gilead, Celgene top the list
Who's most at risk if the U.S. cracks down on prices? Gilead, Celgene top the list
Who's most at risk if the U.S. cracks down on prices? Gilead, Celgene top the list
Submitted by
admin
on September 29, 2015 - 2:17pm
Source:
Fierce Pharma
News Tags:
drug pricing
Celgene
Gilead Sciences
Headline:
Who's most at risk if the U.S. cracks down on prices? Gilead, Celgene top the list
Do Not Allow Advertisers to Use My Personal information
